This video highlights a novel scoring system using microRNA signatures that predicted poor overall survival and bone metastasis in patients with luminal A breast cancer.
Kazuaki Takabe, MD, PhD
Advertisement
Articles by Kazuaki Takabe, MD, PhD
Advertisement
Latest Updated Articles
MicroRNA Signature Predicted Breast Cancer Survival, Bone MetastasisPublished: April 9th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
2
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
3
Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy
4
ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma
5
